It is missing three amino acids at the beginning of the chain, which makes it bind less to carrier proteins and more directly to IGF-1 receptors
The profile of APAP and its glucoronidate and sulfate conjugates in the plasma after a 20 mg/kg dose were studied in[4] and are shown in Figure2B, and the results computed by our model for the same dose are shown in Figure2A
Mechanism of Action: It mimics the action of ghrelin (a hunger hormone) and binds to the ghrelin receptor in the brain, which then triggers the release of growth hormone from the pituitary gland
Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement
The foundational characterisation comes from Raun et al., 1998, who described ipamorelin as "the first selective growth hormone secretagogue." In the taxonomy of research peptides, ipamorelin therefore sits between the older, less selective compounds such as GHRP-2 and GHRP-6 on one side and the GHRH analogues such as CJC-1295 or tesamorelin on the other
